Answers are grounded in this paper and cite their sources.
United States liver transplant policy debate has conflated two distinct mechanisms: Expedited Placement (OPTN Policy 9.10), a formal route for late turndowns when in-sequence offering risks non-utilization, and allocation out-of-sequence (AOOS), informal organ procurement organization (OPO) outreach beyond the match-run. Linking Standard Transplant Analysis and Research files to the Potential Transplant Recipient database (March 2021-December 2025), we classified 61,626 match-runs (41,638 transplanted) by pathway: in-sequence <50 offers (n=32,165), in-sequence ≥50 (n=3,450), AOOS (n=5,486), and Expedited Placement (n=537). AOOS rose 132% while Expedited Placement grew 6% and was absent in 12 of 55 OPOs. Before acceptance, a median 10 centers were contacted per AOOS graft versus 6 in-sequence, and AOOS refusals far more often covered entire waitlists (median 28 patients declined per donor versus 2). Most in-sequence acceptances occurred before donor cross-clamp (median 17.0 hours prior), whereas AOOS and Expedited Placement acceptances occurred after (0.15 and 2.42 hours). AOOS transplants occurred more frequently at centers with higher in-sequence acceptance of hard-to-place organs (Spearman 0.866), with comparable survival. These patterns are consistent with AOOS occurring after in-sequence placement has stalled, rather than as early bypass of in-sequence candidates; the circumstance Expedited Placement was designed for.
No takes yet. Share an insight, caveat, or question.
Attia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: